mounjaro tirzepatide vs semaglutide vs. for Weight Loss Tirzepatide more effective in blood

Over 72 weeks, patients in this dose group lost an average of 16.1 kg (35.5 lb) when used in combination with diet and exercise

Some individuals lost more than 30% when combining the medication with lifestyle changes

The Oxford University 2026 study found that patients who stopped tirzepatide regained an average of 0.8 kg per month, with most returning to their pre-treatment baseline weight within approximately 18 months

The GI side effect timeline provides benchmarks for normal duration versus concerning persistence

Remove the syringe from the vial

Moreover, emphasis on cost-effectiveness and safety across diverse populations enhances clinical utility and implementation potential